Savara Inc.
Savara Inc.
Explore linked clinical trials.2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) | autoimmune pulmonary alveolar proteinosis | Active, not recruiting | Phase 3 | 2026-08-26 | NCT04544293 | |
| Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP). | autoimmune pulmonary alveolar proteinosis, lung disorder, pulmonary alveolar proteinosis, respiratory system disorder | Recruiting | Phase 3 | 2026-02-19 | NCT06431776 |